RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up

Background There is a need for additional longitudinal studies with the Aptima messenger RNA human papillomavirus test (AHPV) to support the safety of extended screening intervals. RNA‐based extended interventional nucleic acid (REINA) provides relevant information on the clinical performance of AHP...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer cytopathology 2024-12, Vol.132 (12), p.757-767
Hauptverfasser:	Granados, Rosario, Duarte, Joanny A., Luján, David R., Gutierrez‐Pecharromán, Ana M., Solís, Isabel, Molpeceres, Lourdes, Bajo, Paloma, Palencia, Elsa, Martín, Nuria
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult cervical cancer clinical performance Early Detection of Cancer - methods Female Follow-Up Studies Human papillomavirus Humans Longitudinal Studies longitudinal study Medical screening Middle Aged mRNA‐based HPV testing Original Papillomaviridae - genetics Papillomaviridae - isolation & purification Papillomavirus Infections - diagnosis Papillomavirus Infections - virology predictive values Prospective Studies REINA RNA, Messenger - analysis RNA, Messenger - genetics RNA, Viral - analysis RNA, Viral - genetics Sensitivity and Specificity Uterine Cervical Dysplasia - diagnosis Uterine Cervical Dysplasia - virology Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - virology Vaginal Smears - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!